# Theragenics

Type: Company

Source: Supply Chain Intelligence Brief — https://getsupplybrief.com/entity/theragenics
Canonical HTML page: https://getsupplybrief.com/entity/theragenics

## Timeline

- **2026-Q3**: Production Ramp-up — Expected commencement of large-scale isotope production for late-stage clinical trials.
- **2026-Q2**: Process Integration — Technical teams begin integrating manufacturing protocols and quality control standards.
- **2026-03-25**: Agreement Signed — Clarity and Theragenics formalize the large-scale manufacturing supply deal for Cu-64.

## Recent coverage (1 stories)

### Clarity and Theragenics Ink Major Copper-64 Manufacturing Supply Deal
2026-03-25 18:03:53 · Sentiment: Positive · Impact: 6/10 · Sources: 2

Clarity Pharmaceuticals has secured a large-scale manufacturing supply agreement with Theragenics for the production of copper-64. This strategic partnership addresses critical supply chain bottlenecks for radiopharmaceuticals, ensuring a reliable flow of isotopes for Clarity’s diagnostic and therapeutic clinical trials.
Full story: https://getsupplybrief.com/story/clarity-theragenics-copper-64-manufacturing-agreement

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getsupplybrief.com/guides/methodology for the full editorial methodology.